Colorado prescription drug board declares Enbrel unaffordable in national first
A Colorado board voted unanimously Feb. 16 to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted territory and setting up a possible showdown with the drug's manufacturer.
Feb 19, 2024
0
0